IKSIT: Internet-delivered CBT for Patients With NCCP

Sponsor
Linkoeping University (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03336112
Collaborator
Ostergotland County Council, Sweden (Other)
109
1
2
62
1.8

Study Details

Study Description

Brief Summary

Non-cardiac chest pain (NCCP) is common and has substantial impact on patients' psychological wellbeing, quality of life and healthcare use. Although cardiac diagnosis is 'ruled out', many patients think they have an undetected cardiac disease (i.e. they suffer cardiac anxiety) as no other explanation is offered. They therefore avoid activities that they believe might be harmful to their heart, leading to greater ill-health, and increased healthcare use and societal costs. Targeting cardiac anxiety with psychological interventions might break this vicious circle and improve patient outcomes. Patients need to evaluate the way they perceive and handle their chest pain, which can be done with cognitive behavioral therapy (CBT).

The aim of this study is therefore to evaluate the short- and long-term effects of an Internet-delivered CBT (I-CBT) program on psychological distress and other patient-reported outcomes in patients with NCCP. A second aim is to explore factors related to implementation of I-CBT in clinical care. The study has a randomized controlled design comparing I-CBT with Internet-delivered information program. Quantitative methods will be used to evaluate the effectiveness of the I-CBT program. Implementation issues will be evaluated from the perspectives of patients, healthcare professionals and policymakers using qualitative methods.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Internet-delivered cognitive behavioral therapy (I-CBT)
  • Other: Information program
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
109 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Internet-delivered Cognitive Behavioral Therapy for Treatment of Cardiac Anxiety in Patients With Non-cardiac Chest Pain - a Randomized Controlled Study
Actual Study Start Date :
Nov 1, 2017
Actual Primary Completion Date :
Oct 9, 2020
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intervention group

5 weeks guided internet-delivered cognitive behavioral therapy program The program consists of psychoeducation, exposure to physical activity, and awareness (mindfulness) training.

Behavioral: Internet-delivered cognitive behavioral therapy (I-CBT)
The intervention (I-CBT) will consist of 5 weeks of Internet-delivered cognitive behavioral therapy using three main parts. The first is psychoeducation that aims to educate the patients about chest pain and other causes than the cardiac ones. The other part concerns avoidance and exposure. This includes exposing the patients to physical activities that patients perceive as a threat to the heart. The third part contains awareness (mindfulness) training to teach the patients to have contact with the present moment despite chest pain and not trying to avoid it.

Active Comparator: Control group

Information program delivered by the Internet during 5 weeks.

Other: Information program
Information program delivered by the Internet during 5 weeks.

Outcome Measures

Primary Outcome Measures

  1. Cardiac anxiety [12 months after end of intervention]

    Cardiac Anxiety Questionnaire (CAQ) will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The CAQ consists of 18 items and a score range between 0 and 72. The higher scores the greater cardiac anxiety.

Secondary Outcome Measures

  1. Fear of body sensations [12 months after end of intervention]

    Body Sensations Questionnaire will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The questionnaire comprises 17 items with scores ranging between 17 and 85 and the higher scores the greater fear of body sensations.

  2. Depressive symptoms [12 months after end of intervention]

    Patient Health Questionnaire-9 will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. This questionnaire comprises 9 items with scores ranging between 0 and 27. Higher scores indicate higher levels of depressive symptoms. A cut-off of 10 demonstrates moderate levels and will be used in this study.

  3. Health-related quality of life [12 months after end of intervention]

    EuroQol-5D (EQ-5D) will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes related to intervention. The EQ-5D includes five dimensions of Health-related quality of life: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension has five levels corresponding to: no problems, slight problems, moderate problems, severe problems and extreme problems/unable. The questionnaire also includes an EQ-VAS, which is a visual analogue scale ranging from 0 (worst health you can imagine) to 100 (best health you can imagine).

  4. Chest pain frequency [12 months after end of intervention]

    Self-developed open questions will be used before and after the intervention (5 weeks), and 3, 6, 12 months after the end of the intervention to assess changes in chest pain related to intervention.

  5. Healthcare use [12 months after end of intervention]

    Care Data Warehouse (Register), data will be collected 12 months after the end of the intervention to assess changes related to intervention.

  6. Societal costs [12 months after end of intervention]

    Cost per patient register and Social Insurance Office register, data will be collected 12 months after the end of the intervention to assess changes related to intervention.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • at least 2 healthcare visits due to NCCP during the last 6 months

  • patients suffering from cardiac anxiety (score ≥ 24 on the Cardiac Anxiety Questionnaire-CAQ)

Exclusion Criteria:
  • language difficulties

  • not able to perform physical activity/exercise due to physical constraints

  • patients with severe depressive symptoms

  • patients with acute ischemic heart disease

  • patients with no access to computer/tablet and/or Internet

Contacts and Locations

Locations

Site City State Country Postal Code
1 Linköping University Linköping Sweden

Sponsors and Collaborators

  • Linkoeping University
  • Ostergotland County Council, Sweden

Investigators

  • Study Chair: Ghassan Mourad, PhD, Linkoeping University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ghassan Mourad, Senior lecturer, Linkoeping University
ClinicalTrials.gov Identifier:
NCT03336112
Other Study ID Numbers:
  • I-CBT for NCCP
First Posted:
Nov 8, 2017
Last Update Posted:
Nov 16, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ghassan Mourad, Senior lecturer, Linkoeping University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 16, 2021